Stella M. Davies

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

John E. Wagner, Juliet N. Barker, Todd E. DeFor et al. · Blood · 2002 · 1K citations

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Kirk R. Schultz, W. Paul Bowman, Alexander Aledo et al. · Journal of Clinical Oncology · 2009 · 700 citations · Full text

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

Craig Kollman, Craig Howe, Claudio Anasetti et al. · Blood · 2001 · 699 citations · Full text

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Richard A. Nash, Joseph H. Antin, Chatchada Karanes et al. · PubMed · 2000 · 591 citations

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Elena J. Orlando, Xia Han, Catherine Tribouley et al. · Nature Medicine · 2018 · 542 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +11